Pharmicell holds a symposium, ‘Stem Cell and Bio-Chemical new drugs development’
Phatmicell(co-headed by Kim, Hyeon-Soo and Kim, Seong-Rae, 005690) announced on 3th that it would hold the 6th Pharmicell regular academic symposium under the theme of ‘Current Status of the next generation Stem Cell and Bio-Chemical new drugs development’ on Friday, 19th of this month.
The symposium is designed to serve as a venue for reviewing the current stratus of adult stem cell and discussing ways forward in regard to developing the next generation stem cell therapeutics and biopharmaceuticals.
The gathering is, specifically, receiving a great deal of attention from the industry as the leading companies including Medi-post, Bio Polymed, Vaxcell-Bio, and Anterogen are participating as speakers along with leading academic researchers.
The symposium provides a total of 4 sessions: △current status of stem cell therapeutics clinical trial, △stem cell therapeutics manufacturing technology, △development of bio-chemical new drugs, △next generation cell therapeutics development technology.
“The symposium holds a significant meaning in that industry, academy, and institutions gather together to discuss in-depth on next generation biopharmaceuticals centered on stem cells for the purpose of industry development. We ask for an active participation from researchers, clinicians and industry insiders,” said Kim Hyun Soo, CEO of Pharmicell.
The conference is held at Militopia Hotel, Wirye New Town and advance registration is available at the Pharmicell website(http://www.pharmicell.com/symposium2016).